HDL Cholesterol Efflux Capacity: Cardiovascular Risk Factor and Potential Therapeutic Target.
- Published in:
- Current Atherosclerosis Reports, 2016, v. 18, n. 1, p. 1, doi. 10.1007/s11883-015-0554-1
- By:
- Publication type:
- Article
Works matching IS 15233804 AND DT 2016 AND VI 18 AND IP 1
Results: 5
1
2
Aspirin for the Primary Prevention of Cardiovascular Disease: In Need of Clarity.
- Published in:
- Current Atherosclerosis Reports, 2016, v. 18, n. 1, p. 1, doi. 10.1007/s11883-015-0555-0
- By:
- Publication type:
- Article
3
The Link Between Obstructive Sleep Apnea and Cardiovascular Disease.
- Published in:
- Current Atherosclerosis Reports, 2016, v. 18, n. 1, p. 1, doi. 10.1007/s11883-015-0556-z
- By:
- Publication type:
- Article
4
The Link Between Inflammatory Disorders and Coronary Heart Disease: a Look at Recent Studies and Novel Drugs in Development.
- Published in:
- Current Atherosclerosis Reports, 2016, v. 18, n. 1, p. 1, doi. 10.1007/s11883-015-0557-y
- By:
- Publication type:
- Article
5
Dual Antiplatelet Therapy in Patients with Stable Ischemic Heart Disease.
- Published in:
- Current Atherosclerosis Reports, 2016, v. 18, n. 1, p. 1, doi. 10.1007/s11883-015-0553-2
- By:
- Publication type:
- Article